AM–Pharma is a biopharmaceutical company developing proprietary recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to transform the treatment prospects for patients ...
Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...
Bioverativ will be an independent, publicly-traded, global biotechnology technology focused on the discovery, research, development and commercialization of therapies for hemophilia and other ...
Cannabis Biotech conducts research to develop innovative cannabinoid products and therapies for the treatment of diseases and their symptoms. Ailments that the company has studied include HIV, ...
Develops novel compounds for cancer treatment. The most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor.
Cellerant is developing novel innate and adaptive immunotherapies for oncology and blood-related disorders, including cell-based and antibody therapeutics.
Corbus Pharmaceuticals is a clinical stage biopharmaceutical company focusing on rare, life-threatening, chronic inflammatory diseases. The Company's lead product candidate, Resunab, is a first- ...
CV Sciences produces both pharmaceuticals and consumer products. The Pharmaceutical Division is developing synthetically‐formulated cannabidiol‐based medicine, pursuing the approval of the U.S. ...
Develops cancer immunotherapies, drug conjugates (PDCs), T-cell engaging Probody bispecifics and ProCAR-NK cell therapies based on Protease-Activated Antibodies, 'Probodies'
